News

Press Releases

Feb 25, 2005

FDA Extends PDUFA Action Date for Nebivolol Tablets to May 31, 2005
Feb 25, 2005

Icahn Denied Temporary Restraining Order Against Mylan
Feb 18, 2005

Mylan Laboratories Annual Meeting to be Held on October 28, 2005

-- Company Also Amends Advance Notice Bylaws --
Feb 10, 2005

Mylan Receives Tentative Approval for Modafinil Tablets
Feb 4, 2005

Mylan Receives FDA Approval for Citalopram Hydrobromide Tablets
Feb 3, 2005

Mylan Reports Third Quarter Earnings
Jan 28, 2005

Mylan Announces Third Quarter Fiscal 2005 Earnings Release Date and Conference Call Information
Jan 28, 2005

Mylan Receives Final FDA Approval for Fentanyl Transdermal System
Jan 18, 2005

Mylan Receives Tentative Approval for Oxybutynin Chloride Extended-release Tablets
Jan 12, 2005

Mylan Comments on King Transaction
Dec 23, 2004

Mylan Receives Approval for Quinapril Tablets, USP
Dec 22, 2004

Mylan's Board Receives and Responds to Icahn Letter
Dec 20, 2004

Mylan Declares Quarterly Cash Dividend
Dec 17, 2004

Mylan Comments on Icahn Letter to Shareholders
Dec 16, 2004

Mylan Receives Approval for Propoxyphene Hydrochloride Capsules USP, 65mg
Dec 15, 2004

Mylan Comments on Icahn's Revised Proxy Statement
Dec 13, 2004

Mylan Responds to Lawsuit Filed by Carl Icahn
Nov 22, 2004

Mylan Laboratories Board of Directors Responds to Icahn Letter
Nov 19, 2004

Mylan Laboratories Comments on Icahn Letter
Nov 9, 2004

Mylan Receives Tentative Approval for Pioglitazone Hydrochloride Tablets
Nov 2, 2004

Mylan Receives Approval for Loxapine Capsules USP
Nov 1, 2004

Mylan Comments on Icahn Letter
Oct 28, 2004

Mylan Reports Second Quarter Earnings and Issues Fiscal 2005 Guidance; Comments on King's Earnings Release
Oct 26, 2004

Mylan to Launch Investor Roadshow
Oct 21, 2004

Mylan Pre-Announces Second Quarter EPS of $0.17-$0.19

Show per page

Mylan: Seeing is Believing

You are leaving Mylan.com

By clicking Continue below you are leaving Mylan.com and going to a third-party site.

Continue

Go back